Mylan announced that the FDA has approved Fenofibrate Tablets, the generic version of AbbVie's Tricor.
Mylan announced the launch of Zolmitriptan Tablets for the treatment of migraine with or without aura in adults.
Teva has launched Levalbuterol Inhalation Solution, the generic version of Sunovion's Xopenex Inhalation Solution. Xopenex is a beta-2 agonist indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years and older with reversible obstructive airway disease.
Metoclopramide Injection, the second drug to be offered in the BD Simplist ready-to-administer line of prefilled generic injectables, has been launched. Metoclopramide is an antiemetic that works by stimulating motility of the upper GI tract without stimulating gastric, biliary, or pancreatic secretions.
Lupin has received final FDA approval for Daysee Tablets, the generic version of Teva's Seasonique Tablets. Seasonique is an oral contraceptive indicated for use by women to prevent pregnancy.
Elite Pharmaceuticals has started shipping to market Phentermine HCl Capsules, the generic version of Teva's Adipex-P. To aid weight loss, Phentermine HCl is a short-term adjunct to a regimen of exercise, behavioral modification and caloric restriction.
InnoPharma's Cosyntropin Injection has launched. The generic version of Amphastar's Cortrosyn is a synthetic ACTH diagnostic agent to screen patients presumed to have adrenocortical insufficiency.
Dr. Reddy's Laboratories has launched Zoledronic Acid Injection, the generic version of Novartis' Reclast. Reclast is used to treat osteoporosis, increase bone mass, and treat Paget's disease of bone.
The FDA has approved the Abbreviated New Drug Application for Acyclovir Ointment (Mylan). The generic version of Valeant's Zovirax Ointment, Acyclovir Ointment is used to manage initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.
Dr. Reddy's Laboratories has launched Zenatane capsules, the generic version of Roche Laboratories' Accutane. Zenatane is indicated for the treatment of severe recalcitrant nodular acne unresponsive to conventional therapy.